The public markets have offered the cannabis industry an avenue for direct growth and business impact. However, as the industry matures private companies are creating alternative options.


The Investing News Network (INN) talked with Diane Scott, CEO of Jamaican Medical Cannabis Corporation (JMCC), about the role of the private sector within the cannabis space at the Lift & Co. (TSXV:LIFT) cannabis expo in Vancouver.

Most recently, JMCC increased its production capacity in Jamaica. This acquisition will produce a minimum of three harvests per year of medical cannabis.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

In an update, the company indicated that during its Q2 2019 it will incorporate an analytical testing lab, as well as processing, extraction, packaging, warehousing and logistics operations. JMCC expects to get inspected for a GMP certification by the end of the period.

As part of the conversation at Lift, Scott broke down the role Canadian firms have in terms of the rest of the world opening to the medical cannabis market.

Speaking in a panel at the business conference portion of the expo, Scott explained that Canadian companies are able to impart knowledge in emerging markets.

“There is a real opportunity in my opinion for Canadian [licensed producers] to have high-quality product to go to these places and import the Canadian product, and quite frankly the Canadian learning and experience, which is a win,” Scott told INN.

Private investment in cannabis market

JMCC is a private venture, and Scott wants to keep it that way — the executive confirmed that despite hearing from potential investors she has no plans to take JMCC public any time soon.

“We’re not going to seek an IPO any time in the near future, but I completely understand the rush that comes with becoming a public company — almost the wooing of the public market,” Scott said.

Codie Sanchez, an investor and partner with CS Ventures, previously told INN that private players are moving closer to the cannabis space in the US. She predicts that venture capital and private equity firms will enter the cannabis market more aggressively.

Don’t forget to follow us @INN_Cannabis for real-time updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

BevCanna Enterprises (CSE:BEV,OTCQQ:BVNNF,FWB:7BC) CEO Marcello Leone shared how the company is scaling up its products to forge partnerships and explore opportunities across Canada, the US and Western Europe. 

“Getting your standard processing license and being fully compliant at a federal level is critical in Canada, and we were successful in getting that done. Now we’re getting ready to launch our Keef line of beverages within the next 45 days,” Leone said. 

As a young company, Leone said BevCanna has only started, but it took a four-pronged approach to make sure that it is a revenue-generating company prepared for the opening of many jurisdictions for CBD-based products.

“We are blessed that we have a beautiful infrastructure of our own, a state-of-the-art bottling facility with a capacity of almost 200 million bottles per annum and a strong balance sheet of $55 million. We are in a strong position to scale and grow this company.”

BevCanna has received a Standard Processing License from Health Canada and is now fully authorized to begin production at its full-service, high-capacity beverage manufacturing facility. The company will begin production of its white-label products, number one US cannabis beverage brand Keef and its in-house beverages through licensed Canadian retailers, positioning the company to fully capitalize on the burgeoning Canadian cannabis-infused beverage sector.

Watch the full interview with CEO Marcello Leone above.

Keep reading... Show less

BioHarvest Sciences (CSE: BHSC) will be presenting at the Benzinga Cleantech Small Cap Conference taking place on April 22, 2021. We invite our shareholders and all interested parties to explore cleantech small cap investment opportunities through two days of networking, dealmaking and discovery.

Sign up to get a free spectator pass for the event: https://www.benzinga.com/events/small-cap/clean-tech/

Keep reading... Show less

Positive distributor feedback and strong consumer interest accelerating launch with distributors

Emerging leader in innovative health and wellness beverages and products, BevCanna Enterprises Inc. ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today that its wholly-owned subsidiary Naturo Group has successfully completed its initial shipment of TRACE plant-based products to one of Japan’s largest beverage distributors.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or the “Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced an additional refreshment of its board of directors to further strengthen its leadership in the cannabis industry.

Keep reading... Show less